← Back to Search
Biologically Active Core/shell Nanoparticles Self-assembled From Cholesterol-terminated PEG-TAT For Drug Delivery Across The Blood-brain Barrier.
L. Liu, K. Guo, J. Lu, S. Venkatraman, Dan Luo, Kian Chye Ng, E. Ling, S. Moochhala, Yi-Yan Yang
Published 2008 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
Biologically active polymer core/shell nanoparticles (i.e. micelles) self-assembled from TAT-poly(ethylene glycol) (PEG)-b-cholesterol (TAT-PEG-b-Chol) were fabricated and used as carrier for targeted blood-brain barrier delivery of antibiotics. Ciprofloxacin as a model antibiotic was efficiently loaded into the nanoparticles by a membrane dialysis method. The actual loading level of ciprofloxacin was dependent on initial loading of ciprofloxacin and fabrication temperature. The blank and ciprofloxacin-loaded nanoparticles were characterized using dynamic light scattering and SEM. The nanoparticles were spherical in nature, having an average size lower than 200 nm. The uptake of nanoparticles with TAT by human brain endothelial cells was greater than that of the nanoparticles without TAT. Most importantly, the nanoparticles with TAT were able to cross the blood-brain barrier (BBB), and located around the cell nucleus of neurons. These nanoparticles may provide a promising carrier to deliver antibiotics across the BBB for the treatment of brain infection.
This paper references
Enzymatic rotating biosensor for ciprofloxacin determination.
A. A. Torriero (2006)
Synthesis and Cell‐Imaging Applications of Glutathione‐Capped CdTe Quantum Dots
Y. Zheng (2007)
The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
A. Ziegler (2005)
Block copolymer micelles for drug delivery: design, characterization and biological significance.
K. Kataoka (2001)
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
W. Lu (2005)
Drug-induced aseptic meningitis in suspected central nervous system infections
L. Kępa (2005)
Preformed microcapsules for loading and sustained release of ciprofloxacin hydrochloride.
Z. Mao (2005)
Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.
P. Couvreur (1982)
The Blood‐brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System
D. Begley (1996)
The prophylaxis and treatment of anthrax.
I. Brook (2002)
Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery
P. Calvo (2004)
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
W. Pardridge (1991)
Thermosensitive Y-shaped micelles of poly(oleic acid-Y-N-isopropylacrylamide) for drug delivery.
Yong-Yong Li (2006)
Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.
Y. Aktaş (2005)
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
A. Gulyaev (2004)
Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots.
S. Santra (2005)
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier.
L. Costantino (2005)
In vivo protein transduction: delivery of a biologically active protein into the mouse.
S. Schwarze (1999)
The Study on Brain Targeting of the Amphotericin B Liposomes
X. Zhang (2003)
This paper is referenced by
Biomaterials for promoting brain protection, repair and regeneration
G. Orive (2009)
Advances in Neurotherapeutic Delivery Technologies
V. Pillay (2015)
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Todd O. Pangburn (2009)
Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
Dinesh M Pardhi (2020)
Heterobifunctional poly(ε-caprolactone): Synthesis of α-cholesterol-ω-pyrene PCL via combination of ring-opening polymerization and “click” chemistry
Sevinc Ilkar Erdagi (2016)
Overcoming the Blood-Brain Barrier in Chemotherapy Treatment of Pediatric Brain Tumors
Linfeng Wu (2013)
Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects
P. C. Sharma (2010)
Drug releasing behavior of hybrid micelles containing polypeptide triblock copolymer.
Jiaping Lin (2009)
Multi-morphological biodegradable PLGE nanoparticles and their drug release behavior.
Hanwei Zhang (2009)
Preparation, physicochemical characterization and anti-fungal evaluation of the Nystatin-loaded Eudragit RS100/PLGA nanoparticles
Ghobad Mohammadi (2017)
Photoacoustic molecular imaging using combined acupuncture and gold nanorods as a composite contrast agent
D. Wu (2019)
Lipid and Cyclodextrin Nanocarriers Loading Bioactive Agents:: Stabilization on Polymeric Supports
Atul Tiwari (2013)
Synthesis of terpene–poly(ethylene oxide)s by t-BuP4-promoted anionic ring-opening polymerization
J. Zhao (2012)
Brain-Targeting Mechanisms of Lactoferrin-Modified DNA-Loaded Nanoparticles
R. Huang (2009)
Physicochemical properties of lipid nanoparticles: Effect of lipid and surfactant composition
S. Martins (2011)
Novel multifunctional polyethylene glycol-transactivating-transduction protein-modified liposomes cross the blood-spinal cord barrier after spinal cord injury
Y. Liu (2010)
A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase.
Yi-Ping Chen (2013)
PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier.
H. Wang (2010)
New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes
Shi-jie Gao (2017)
Ligand-mediated transport of drug delivery devices across the blood-brain barrier
Julia V. Georgieva (2012)
Recent advances in cathode materials for Li–S battery: structure and performance
C. Li (2017)
Diagnostic and therapeutic uses of nanomaterials in the brain.
E. Garbayo (2014)
Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
C. Curtis (2017)
Renewable Biomaterials as Nanocarriers for Drug and Gene Delivery
Shi-miao Zhang (2017)
Microspheres for targeting delivery to brain
Chen Jiang (2013)
Nanomedicines for Brain Drug Delivery
Javier O Morales (2021)
Poly(ε-caprolactone)-Block-poly(ethyl Ethylene Phosphate) Micelles for Brain-Targeting Drug Delivery: In Vitro and In Vivo Valuation
P. Zhang (2010)
Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
N. Denora (2009)
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
R. Gabathuler (2010)
Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
C. Velasco-Aguirre (2015)
Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.
Yao Qin (2011)
Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.
H. Xia (2011)See more